Here in the U.S., many startups are facing hard questions about how they’ve grown: bloated valuations, misaligned incentives, shallow product pipelines. The contrast with Korea’s quiet biotech ascent ...

We came across a bullish thesis on Bio-Techne Corporation (TECH) on scuttleblurb’s Substack. In this article, we will ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...